SUPN Operating Cash Flow (Statement)
Supernus Pharmaceuticals Inc · Operating Cash Flow (Statement)
SUPN Operating Cash Flow (Statement)
Latest reported$19.91Mperiod ending
SUPN TTM Cash from Operations (-$36.19M → $19.91M)
TTM operating cash flow (statement)
High-resolution chart · PNG
SUPN operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 19,911,000 | |
| 83,256,000 | |
| 47,331,000 | |
| 71,876,000 | |
| 187,060,000 | |
| 164,149,000 | |
| 171,951,000 | |
| 172,503,000 | |
| 154,858,000 | |
| 100,360,000 | |
| 111,085,000 | |
| 93,691,000 | |
| 71,657,000 | |
| 161,650,000 | |
| 116,826,000 | |
| 138,025,000 | |
| 120,074,000 | |
| 95,229,000 | |
| 127,127,000 | |
| 110,297,000 | |
| 120,006,000 | |
| 165,683,000 | |
| 138,399,000 | |
| 150,257,000 | |
| 182,316,000 | |
| 119,052,000 | |
| 143,129,000 | |
| 132,187,000 | |
| 156,977,000 | |
| 134,846,000 | |
| 128,986,000 | |
| 132,472,000 | |
| 109,029,000 | |
| 128,415,000 | |
| 114,640,000 | |
| 103,243,000 | |
| 92,477,000 | |
| 83,312,000 | |
| 66,812,000 | |
| 61,808,000 | |
| 30,586,000 | |
| 28,478,000 | |
| 32,123,000 | |
| 19,183,000 | |
| 48,949,000 | |
| 27,340,000 | |
| 7,733,000 | |
| -8,682,000 | |
| -51,015,000 | |
| -59,830,000 | |
| -57,949,000 | |
| -64,668,000 | |
| -60,420,000 | |
| -54,354,000 | |
| -47,199,000 | |
| -39,280,000 | |
| -37,117,000 | |
| -36,452,000 | |
| -36,185,000 | |
| -39,668,236 | |
| -39,889,460 |